Page last updated: 2024-08-21

quinazolines and epothilone b

quinazolines has been researched along with epothilone b in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hayakawa, Y	1
Bekier, ME; Fischbach, R; Lee, J; Taylor, WR	1
Egerton, N	1

Reviews

1 review(s) available for quinazolines and epothilone b

Article	Year
Optimizing ixabepilone treatment schedules in patients with advanced or metastatic breast cancer. Cancer chemotherapy and pharmacology, 2010, Volume: 66, Issue:6 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Marrow; Breast Neoplasms; Capecitabine; Clinical Trials, Phase II as Topic; Deoxycytidine; Disease Progression; Drug Administration Schedule; Drug Interactions; Epothilones; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Lapatinib; Lymphatic Metastasis; Peripheral Nervous System Diseases; Quinazolines; Treatment Failure; Treatment Outcome; Tubulin Modulators	2010

Article

Year

Optimizing ixabepilone treatment schedules in patients with advanced or metastatic breast cancer.

Cancer chemotherapy and pharmacology, 2010, Volume: 66, Issue:6

Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Marrow; Breast Neoplasms; Capecitabine; Clinical Trials, Phase II as Topic; Deoxycytidine; Disease Progression; Drug Administration Schedule; Drug Interactions; Epothilones; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Lapatinib; Lymphatic Metastasis; Peripheral Nervous System Diseases; Quinazolines; Treatment Failure; Treatment Outcome; Tubulin Modulators

2010

Other Studies

2 other study(ies) available for quinazolines and epothilone b

Article	Year
[Structure-activity relationship analysis]. Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:4 Topics: Antineoplastic Agents; Benzamides; Camptothecin; Docetaxel; Drug Screening Assays, Antitumor; Epothilones; Gefitinib; Imatinib Mesylate; Irinotecan; Macrolides; Oligopeptides; Paclitaxel; Piperazines; Pyrimidines; Quinazolines; Structure-Activity Relationship; Taxoids; Topotecan; Vinblastine	2004
Length of mitotic arrest induced by microtubule-stabilizing drugs determines cell death after mitotic exit. Molecular cancer therapeutics, 2009, Volume: 8, Issue:6 Topics: Benzamides; Caspase 3; Cell Death; Cell Proliferation; Cell Survival; Cyclin B; Cyclin B1; Epothilones; Fluorescent Antibody Technique; G1 Phase; HeLa Cells; Humans; Mitosis; Nocodazole; Paclitaxel; Quinazolines; Time Factors; TNF-Related Apoptosis-Inducing Ligand; Tubulin Modulators	2009

Article

Year

[Structure-activity relationship analysis].

Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:4

Topics: Antineoplastic Agents; Benzamides; Camptothecin; Docetaxel; Drug Screening Assays, Antitumor; Epothilones; Gefitinib; Imatinib Mesylate; Irinotecan; Macrolides; Oligopeptides; Paclitaxel; Piperazines; Pyrimidines; Quinazolines; Structure-Activity Relationship; Taxoids; Topotecan; Vinblastine

2004

Length of mitotic arrest induced by microtubule-stabilizing drugs determines cell death after mitotic exit.

Molecular cancer therapeutics, 2009, Volume: 8, Issue:6

Topics: Benzamides; Caspase 3; Cell Death; Cell Proliferation; Cell Survival; Cyclin B; Cyclin B1; Epothilones; Fluorescent Antibody Technique; G1 Phase; HeLa Cells; Humans; Mitosis; Nocodazole; Paclitaxel; Quinazolines; Time Factors; TNF-Related Apoptosis-Inducing Ligand; Tubulin Modulators

2009